
Nathsons Pharmaceuticals Private Limited
Pharmaceutical trading company offering a variety of medications and supplements.
Pharmaceutical trading company offering a variety of medications and supplements.
Nathsons Pharmaceuticals Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 August 1991 and has a history of 33 years and seven months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.50 M and a paid-up capital of Rs 3.43 M.
The company currently has active open charges totaling ₹3.69 Cr. The company has closed loans amounting to ₹1.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sudhir Goyal and Madhu Goyal serve as directors at the Company.
Delhi, India
+91-XXXXXXXXXX
U74899DL1991PTC045508
045508
Private Limited Indian Non-Government Company
29 Aug 1991
30 Sep 2024
31 Mar 2024
Unlisted
Roc Delhi
Nathsons Pharmaceuticals Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Anti Infective Drugs & Medicines, Antiviral Drugs, Rapid Test Kit.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sudhir Goyal ![]() | Managing Director | 29-Aug-1991 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Madhu Goyal ![]() | Whole-Time Director | 24-Aug-2007 | Current |
Nathsons Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.54% increase. The company also saw a substantial improvement in profitability, with a 129.92% increase in profit. The company's net worth Soared by an impressive increase of 14.44%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2020, Nathsons Pharmaceuticals had a promoter holding of 99.63% and a public holding of 0.37%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹36.93 M
₹16.00 M
Date | Lender | Amount | Status |
---|---|---|---|
01 Feb 2022 | Others | ₹4.40 M | Open |
11 Jun 2012 | Bank Of Baroda | ₹0.90 M | Open |
12 May 2012 | Bank Of Baroda | ₹0.35 M | Open |
08 Oct 2010 | Bank Of Baroda | ₹3.00 Cr | Open |
08 Oct 2010 | Bank Of Baroda | ₹0.30 M | Open |
Unlock and access historical data on people associated with Nathsons Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nathsons Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nathsons Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nathsons Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Nathsons Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
A charge with Others amounted to Rs. 4.40 M with Charge ID 100556195 was registered on 01 Feb 2022.
A charge with Bank Of Baroda of Rs. 30.00 M registered on 08 Oct 2010 with Charge ID 10244266 was modified on 06 Sep 2013.
A charge with Bank Of Baroda amounted to Rs. 0.90 M with Charge ID 10363575 was registered on 11 Jun 2012.
A charge registered on 25 Jan 2012 via Charge ID 10333566 with Bank Of Baroda was fully satisfied on 14 May 2012.
Nathsons Pharmaceuticals Private Limited was incorporated on 29 Aug 1991.
The authorized share capital of Nathsons Pharmaceuticals Private Limited is ₹ 6.50 M and paid-up capital is ₹ 3.43 M.
Currently 2 directors are associated with Nathsons Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Nathsons Pharmaceuticals Private Limited is 5C/9 Ist Floor New Rohtak Road India, New Delhi, 110005.
The corporate identification number (CIN) of Nathsons Pharmaceuticals Private Limited is U74899DL1991PTC045508 and the company number is 045508 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Nathsons Pharmaceuticals Private Limited has risen by 4.54%.
The financial reports for the fiscal year 2022 indicates that The net worth of Nathsons Pharmaceuticals Private Limited has experienced an upsurge of 14.44%.
As per the financial statements for fiscal Year 2022, The total open charges for Nathsons Pharmaceuticals Private Limited amount to ₹ 3.69 Cr.
The most recent Balance Sheet for Nathsons Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
VD
RS
RG